CRDF

Cardiff Oncology, Inc.

Company with tickers: CRDF

CIK

1213037

CUSIP

14147L108

Shares Outstanding

68,369,896

13F Activity (30d)

49 filings 47 filers

Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.

Fiscal Year Ended	Cash Spent	Shares	Avg Price	Source
2014-03-31	$500,000	—	—	10-Q, filed 2014-05-12
2013-12-31	$500,000	—	—	10-K, filed 2014-03-17
2013-09-30	$500,000	—	—	10-Q, filed 2013-11-14
2013-06-30	$500,000	—	—	10-Q, filed 2013-08-14
2013-03-31	$500,000	—	—	10-Q, filed 2013-05-14
2012-12-31	$500,000	—	—	10-K, filed 2013-04-01
2012-09-30	$500,000	—	—	10-Q, filed 2012-11-14
2012-06-30	$500,000	—	—	10-Q, filed 2012-08-14
2012-03-31	$500,000	—	—	10-Q, filed 2012-05-15

Recent quarters

Quarter Ended	Cash Spent	Shares	Avg Price	Source
2014-03-31	$0 Δ	—	—	10-Q, filed 2014-05-12
2013-12-31	$0 Δ	—	—	10-K, filed 2014-03-17
2013-09-30	$0 Δ	—	—	10-Q, filed 2013-11-14
2013-06-30	$0 Δ	—	—	10-Q, filed 2013-08-14
2013-03-31	$0 Δ	—	—	10-Q, filed 2013-05-14
2012-12-31	$0 Δ	—	—	10-K, filed 2013-04-01
2012-09-30	$0 Δ	—	—	10-Q, filed 2012-11-14
2012-06-30	$0 Δ	—	—	10-Q, filed 2012-08-14